| Larissa Michele Murphey, PA | |
|
115 Porter Dr, Middlebury, VT 05753-8629 | |
| (802) 388-8842 | |
| Not Available |
| Full Name | Larissa Michele Murphey |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 6 Years |
| Location | 115 Porter Dr, Middlebury, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558839043 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lakes Region General Hospital | Laconia, NH | Hospital |
| Speare Memorial Hospital | Plymouth, NH | Hospital |
| Franklin Memorial Hospital | Farmington, ME | Hospital |
| Porter Hospital, Inc | Middlebury, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Porter Hospital Inc | 1850365180 | 59 |
| Speare Memorial Hospital | 1153318068 | 39 |
| Concord Hospital-laconia | 7012326259 | 202 |
| Mainehealth | 7517860588 | 2067 |
News Archive
You probably know your blood type: A, B, AB or O. You may even know if you're Rhesus positive or negative. But how about the Langereis blood type? Or the Junior blood type? Positive or negative? Most people have never even heard of these.
Older parents are more likely to have a child who develops an autism spectrum disorder (ASD) than are younger parents. A recent study from researchers from the Drexel University School of Public Health in Philadelphia and Karolinska Institute in Sweden provides more insight into how the risk associated with parental age varies between mothers' and fathers' ages, and found that the risk of having a child with both ASD and intellectual disability is larger for older parents.
Researchers funded by the National Institutes of Health have discovered how a defect in a single master gene disrupts the process by which several genes interact to create myelin, a fatty coating that covers nerve cells and increases the speed and reliability of their electrical signals.
The US Food and Drug Administration (FDA) has approved Zortress® (everolimus) oral tablets for the prevention of rejection of kidney transplants in adult patients at low-to-moderate immunologic risk. Zortress is to be given in combination with reduced doses of the calcineurin inhibitor (CNI) cyclosporine, as well as basiliximab and corticosteroids.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that the Marketing Authorisation Application (MAA) for Glybera(R) remains on schedule following meetings with the European Medicine Agency (EMA) concerning the Day 120 List of Questions. The company is confident that Glybera(R), a gene therapy product for lipoprotein lipase deficiency (LPLD), remains on track for a regulatory decision by mid-2011.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Larissa Michele Murphey, PA Po Box 582, Meredith, NH 03253-0582 Ph: () - | Larissa Michele Murphey, PA 115 Porter Dr, Middlebury, VT 05753-8629 Ph: (802) 388-8842 |
News Archive
You probably know your blood type: A, B, AB or O. You may even know if you're Rhesus positive or negative. But how about the Langereis blood type? Or the Junior blood type? Positive or negative? Most people have never even heard of these.
Older parents are more likely to have a child who develops an autism spectrum disorder (ASD) than are younger parents. A recent study from researchers from the Drexel University School of Public Health in Philadelphia and Karolinska Institute in Sweden provides more insight into how the risk associated with parental age varies between mothers' and fathers' ages, and found that the risk of having a child with both ASD and intellectual disability is larger for older parents.
Researchers funded by the National Institutes of Health have discovered how a defect in a single master gene disrupts the process by which several genes interact to create myelin, a fatty coating that covers nerve cells and increases the speed and reliability of their electrical signals.
The US Food and Drug Administration (FDA) has approved Zortress® (everolimus) oral tablets for the prevention of rejection of kidney transplants in adult patients at low-to-moderate immunologic risk. Zortress is to be given in combination with reduced doses of the calcineurin inhibitor (CNI) cyclosporine, as well as basiliximab and corticosteroids.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that the Marketing Authorisation Application (MAA) for Glybera(R) remains on schedule following meetings with the European Medicine Agency (EMA) concerning the Day 120 List of Questions. The company is confident that Glybera(R), a gene therapy product for lipoprotein lipase deficiency (LPLD), remains on track for a regulatory decision by mid-2011.
› Verified 1 days ago
Mr. Jeffrey Peter Abell, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 82 Catamount Park, Middlebury, VT 05753 Phone: 802-388-6777 | |
Mrs. Kristin Alana Schiller, MPAS, MS, PA-C, RDN Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 115 Porter Dr, Middlebury, VT 05753 Phone: 802-388-7037 | |
Mr. Luc Hilaire Dupuis, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1436 Exchange St, Middlebury, VT 05753 Phone: 802-388-3194 Fax: 802-388-4881 | |
Ms. Hylah W Patton, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 115 Porter Dr, Middlebury, VT 05753 Phone: 802-388-4701 Fax: 802-388-5654 | |
Kathryn Zoll, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 115 Porter Dr, Middlebury, VT 05753 Phone: 802-388-4701 | |
Hadley Christine Warner, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 115 Porter Dr, Middlebury, VT 05753 Phone: 802-989-1706 |